Europe lifts warning on Pfizer smoking cessation drug

LONDON (Reuters) – European regulators have lifted a warning on Pfizer’s smoking cessation drug Champix – called Chantix in the United States – after a clinical study concluded it did not appear to increase the risk of neuropsychiatric side effects.

Advertisements
Europe lifts warning on Pfizer smoking cessation drug

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s